SLAMF7-CAR T cell treatment of Multiple Myeloma patients
5 (110) · € 38.00 · Auf Lager
Selected non-BCMA CAR T-cell clinical trials in multiple myeloma.
PDF] Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myeloma
Vaccines, Free Full-Text
Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7: Molecular Therapy
Selective elimination of immunosuppressive T cells in patients with multiple myeloma
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
CARAMBA EU project: SLAMF7 CAR-T treatment of multiple myeloma
Multiple myeloma cells expressing SLAMF7 and targeting them with CAR-T
JCM, Free Full-Text
